We are live on
!
Find out more
GBA
Garrison Bradford & Associates Portfolio holdings
AUM
$92.2M
1-Year Est. Return
19.08%
This Fund
S&P 500
This Quarter
Est. Return
+8.73%
1 Year Est. Return
+19.08%
3 Year Est. Return
+63.45%
5 Year Est. Return
+93.47%
10 Year Est. Return
+398.58%
AUM
$96.2M
AUM Growth
+$6.5M
(+7.2%)
Cap. Flow
-$934K
Cap. Flow
% of AUM
-0.97%
Top 10 Holdings %
Top 10 Hldgs %
69.69%
Holding
53
New
2
Increased
8
Reduced
14
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GM
GEN MOTORS CORP
GM
|
+$337K |
| 2 |
Walker & Dunlop
WD
|
+$262K |
| 3 |
United Parcel Service
UPS
|
+$200K |
| 4 |
Microsoft
MSFT
|
+$112K |
| 5 |
WisdomTree Europe SmallCap Dividend Fund
DFE
|
+$44.7K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Woodward
WWD
|
+$438K |
| 2 |
UnitedHealth
UNH
|
+$318K |
| 3 |
Acadia Pharmaceuticals
ACAD
|
+$227K |
| 4 |
Enterprise Products Partners
EPD
|
+$196K |
| 5 |
Old Dominion Freight Line
ODFL
|
+$154K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.83% |
| 2 | Financials | 14.52% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Industrials | 11.31% |
| 5 | Technology | 6.95% |
Similar funds
AW
JBL
YC
MA
ITG
ACMC
KAM
KA
Garrison Bradford & Associates's Q2 2021 Portfolio in Review
As of Q2 2021, Garrison Bradford & Associates held 53 positions worth $96.2M, up 7.2% from $89.7M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Garrison Bradford & Associates's Q2 2021 filing shows 2 new, 8 increased, 14 reduced and 1 closed positions. Its largest new stake was Walker & Dunlop: 2,500 shares worth $261K. The largest sale was Woodward, an estimated $438K.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 36% a quarter earlier, followed by Financials and Consumer Discretionary.
- Garrison Bradford & Associates's largest Q2 2021 buy was Walker & Dunlop: 2,500 shares worth $261K.
- Garrison Bradford & Associates added most to GEN MOTORS CORP in Q2 2021, an estimated $337K increase.
- Garrison Bradford & Associates's biggest Q2 2021 reduction was Woodward, cutting an estimated $438K.
- Garrison Bradford & Associates fully exited Acadia Pharmaceuticals in Q2 2021, selling an estimated $227K.
- Garrison Bradford & Associates's ten largest holdings make up 70% of its $96.2M portfolio in Q2 2021.
- Garrison Bradford & Associates opened 2 new positions and closed 1 in Q2 2021.
- Garrison Bradford & Associates's portfolio value rose 7.2% quarter-over-quarter to $96.2M.
Based on Garrison Bradford & Associates's 13F filing for Q2 2021, filed 9 Aug 2021.